Stay Connected
Join us on Facebook Follow us on Twitter Follow us on linked in Follow us on YouTube
Reporting Actual or Suspected Violations
request info

Medpace is ready to help you with your next clinical trial project. Find out more about how we can help.

GO NOW more


GENERAL CAPABILITIES


EVENTS

May 18 - 21, 2013

Medpace will attend Digestive Disease Week in Orlando.

May 20 - 22, 2013

Medpace will speak at the Global Clinical Trials Outsourcing Summit in Seoul.

May 22 - 23, 2013

Medpace will speak at Partnerships in Clinical Trials Russia in Istanbul.

May 23 - 24, 2013

Medpace will sponsor the Neurotech Investing & Partnering Conference in St. Regis San Francisco.

May 28 - 31, 2013

Medpace will attend the New Clinical Drug Evalutation Unit Annual Meeting (NCDEU) in Hollywood.

May 29 - 30, 2013

Medpace will attend the New York Biotechnology Association (NYBA) Annual Meeting in New York City.

May 31 - June 4, 2013

Medpace will exhibit at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

June 2 - 5, 2013

Medpace will attend the 81st Congress of the European Atherosclerosis Society in Lyon.

June 12 - 13, 2013

Medpace will exhibit at Outsourcing in Clinical Trials: Medical Devices & Diagnostics in St. Paul.

June 12 - 13, 2013

Medpace will attend Anglonordic Medtech Conference II and Anglonordic Biotech Conference X in London.

June 21 - 25, 2013

Medpace will exhibit at the American Diabetes Association's 73rd Scientific Sessions in Chicago.

June 23 - 27, 2013

Medpace will exhibit at the DIA Annual Meeting in Boston.

July 17 - 18, 2013

Medpace will exhibit at Clinical Operations in Oncology Trials USA in Boston.



Request a Meeting



VIEW ALL EVENTS

Effective Date: 7-FEB-2012

  • All reports of actual or suspected violations of the General and Financial Code of Ethics or the Policy on Compliance With Anti-Bribery and Corruption Laws must be made to the Corporate Compliance Officer or the Chair of the Audit Committee of the Board of Directors immediately upon discovery.
  • The Corporate Compliance Officer or the representative of the Audit Committee may be notified in person, via US mail, by telephone or via email as follows:

    Corporate Compliance Officer
    Stephen Ewald
    Medpace Corporate Headquarters
    5375 Medpace Way
    Cincinnati, Ohio 45227, USA

    Tel: +1.513.579.9911, ext. 2055
    Fax: +1.513.579.0444
    E-mail: compliance@medpace.com; or s.ewald@medpace.com

  • From inside the US: Medpace phone number: 513/579-9911 x 2898; or toll free long distance within the US: 877/394-3528.
  • From outside the US: From inside Medpace international offices, dial extension 2898; or to make a toll free call from outside Medpace offices, go to the company's Sharepoint site using the link below, call the phone number listed next to your country name, then enter extension 2898 when the directory prompts you for an extension number.
  • Medpace Toll-Free Numbers
  • Contact the representative of the Medpace Audit Committee:

    Chair of the Audit Committee
    Neil McCarthy, JD
    Managing Director
    Fairmount Partners
    100 Four Falls Corporate Center
    Suite 660
    West Conshohocken, PA 19428
    Tel: +1.610.260.6224

  • E-mail: neil.mccarthy@fairmountpartners.com

About Reporting

  • All employees are held accountable for their actions and are required to report unethical or unlawful activities. Managers are ultimately responsible for ensuring that the employees they supervise are knowledgeable about and in compliance with the contents of this Employee Handbook. Any employee who violates any of the codes or policies in this Employee Handbook, or who is aware of, but fails to report any such violation or any other unlawful or unethical business behavior, is subject to disciplinary action, including termination of employment and/or legal action.
  • Reasonable judgment must be exercised to avoid baseless allegations. An employee who intentionally files a false report of wrongdoing will be subject to discipline up to and including termination. Employees who file reports in good faith will not be subject to discipline.
  • Retaliation for filing a report is prohibited. Any employee who has reported what he/she believes to be illegal or unethical activity or a violation of the codes or policies in this Employee Handbook, and who believes he/she is being retaliated against must contact the Corporate Compliance Officer immediately. The right of an employee for protection against retaliation does not include immunity for any personal wrongdoing that is alleged or discovered in the course of the investigation.
  • Anonymous reports will be accepted, but those making a report are encouraged to identify themselves in case more information is needed during the investigation. To the extent possible, the confidentiality of the person filing the report will be maintained. However, identity may have to be disclosed to conduct a thorough investigation, to comply with the law and to provide accused individuals their legal rights of defense.
  • A person making a report is not responsible for investigating the activity or for determining fault or corrective measures. Appropriate management officials are charged with these responsibilities.